Form 4 for ANIX Anixa Biosciences Inc
Accepted 2023-07-31 00:00:00 ET · period of report 2023-07-28 · accession 0001493152-23-026125 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-07-31 | 2023-07-28 | ANIX | KUMAR AMIT | CEO, Dir | M - OptEx | $2.58 | +40.0K | 502.1K | +9% | +$103.2K |
| D | 2023-07-31 | 2023-07-31 | ANIX | KUMAR AMIT | CEO, Dir | S - Sale+OE | $3.57 | -11.8K | 461.9K | -2% | -$42.1K |
| D | 2023-07-31 | 2023-07-28 | ANIX | KUMAR AMIT | CEO, Dir | F - Tax | $3.63 | -28.4K | 473.7K | -6% | -$103.0K |
| D | 2023-07-31 | 2023-07-28 | ANIX | KUMAR AMIT | CEO, Dir | M - OptEx | $0.00 | -40.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-28 | M | A | 40,000 | $2.58 | 502,100 | D | — | — | |
| 2 | Common | Common Stock | 2023-07-31 | S | D | 11,800 | $3.57 | 461,925 | D | — | — | |
| 3 | Common | Common Stock | 2023-07-28 | F | D | 28,375 | $3.63 | 473,725 | D | — | — | |
| 4 | Derivative | Employee Stock Option (Right to Buy) | 2023-07-28 | M | D | 40,000 | $0.00 | 0 | D | $2.58 · 2013-11-08 to 2023-11-08 | 40,000 Common Stock | (F2) Right-To-Buy, pursuant to a stock option grant dated November 8, 2013. |